Protagonist Therapeutics, Inc Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Protagonist Therapeutics, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q2 2024.
  • Protagonist Therapeutics, Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 61.3M shares, a 7.98% increase year-over-year.
  • Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 56.8M shares, a 15.7% increase from 2022.
  • Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 49M shares, a 5.87% increase from 2021.
  • Protagonist Therapeutics, Inc annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 46.3M shares, a 34.7% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 61.3M +4.53M +7.98% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 60.9M +10.3M +20.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 56.8M +7.72M +15.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 59.2M +10.1M +20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 56.8M +7.73M +15.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 50.6M +1.82M +3.74% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 49M +2.72M +5.87% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 49.1M +1.12M +2.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 49M +4.19M +9.33% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 48.8M +4.53M +10.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 46.3M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 48M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 44.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 44.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.